Vincent Ling

9.3k total citations · 2 hit papers
49 papers, 7.6k citations indexed

About

Vincent Ling is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Vincent Ling has authored 49 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 15 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Vincent Ling's work include T-cell and B-cell Immunology (20 papers), Immune Cell Function and Interaction (15 papers) and Immune Response and Inflammation (7 papers). Vincent Ling is often cited by papers focused on T-cell and B-cell Immunology (20 papers), Immune Cell Function and Interaction (15 papers) and Immune Response and Inflammation (7 papers). Vincent Ling collaborates with scholars based in United States, Canada and United Kingdom. Vincent Ling's co-authors include Mary Collins, Beatriz M. Carreno, Tatyana Chernova, Lynette A. Fouser, Hiroyuki Nishimura, Taku Okazaki, Michael Bowman, Yoshiko Iwai, Andrew J. Long and Lori Fitz and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Vincent Ling

49 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

2000 4.2k citations Tatyana Chernova, Lynette A. Fouser et al. profile →
ICOS is critical for CD40-mediated antibody class switching

2001 526 citations Alexander J. McAdam, Rebecca J. Greenwald et al. Nature profile →

Peers

Countries citing papers authored by Vincent Ling

Since Specialization

Citations

This map shows the geographic impact of Vincent Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Ling more than expected).

Fields of papers citing papers by Vincent Ling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Ling. The network helps show where Vincent Ling may publish in the future.

Co-authorship network of co-authors of Vincent Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Ling. A scholar is included among the top collaborators of Vincent Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Ling. Vincent Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Polymeric micelles for cutaneous delivery of the hedgehog pathway inhibitor TAK-441: Formulation development and cutaneous biodistribution in porcine and human skin 2023 ·International Journal of Pharmaceutics ·(unknown), Maria Lapteva, Vincent Ling, Yogeshvar N. Kalia	6
2	Targeted cutaneous delivery of etanercept using Er:YAG fractional laser ablation 2020 ·International Journal of Pharmaceutics ·Sergio del Río‐Sancho, Maria Lapteva, Kiran Sonaje, (unknown), Vincent Ling, Wolf‐Henning Boehncke, Yogeshvar N. Kalia	22
3	Wellness Programs 2012 ·Journal of the American College of Radiology ·(unknown), Vincent Ling, (unknown), (unknown), Saurabh Kumar Jha	1
4	Long-Term, Sustained Intraocular Delivery of a VEGF Antagonist Using Encapsulated Cell Technology Implant for the Treatment of Choroidal Neovascular Diseases 2012 ·Investigative Ophthalmology & Visual Science ·Konrad Kauper, Vincent Ling, (unknown), (unknown), S. Sherman, (unknown), Lisa D. Orecchio, (unknown), (unknown), Weng Tao	1
5	Antagonists to Human and Mouse Vascular Endothelial Growth Factor Receptor 2 Generated by Directed Protein Evolution In Vitro 2006 ·Chemistry & Biology ·E. V. Getmanova, Yan Chen, Laird Bloom, Jochem Gokemeijer, Steven M. Shamah, Veena Warikoo, Jack Wang, Vincent Ling, Lin Sun	74
6	No major effect of theCD28/CTLA4/ICOSgene region on susceptibility to primary sclerosing cholangitis 2006 ·Scandinavian Journal of Gastroenterology ·Kristine Wiencke, Kirsten Muri Boberg, Peter T. Donaldson, Hanne F. Harbo, Vincent Ling, Erik Schrumpf, Anne Spurkland	6
7	The B7 family of immune-regulatory ligands. 2005 ·Genome Biology ·Mary Collins, Vincent Ling, Beatriz M. Carreno	258
8	Conversion of CTLA-4 from Inhibitor to Activator of T Cells with a Bispecific Tandem Single-Chain Fv Ligand 2004 ·The Journal of Immunology ·Joaquı́n Madrenas, Luan A. Chau, Wendy A. Teft, Paul W. Wu, Jason Jussif, Marion T. Kasaian, Beatriz M. Carreno, Vincent Ling	26
9	Induction of Tumor Regression by Administration of B7-Ig Fusion Proteins: Mediation by Type 2 CD8+ T Cells and Dependence on IL-4 Production 2004 ·The Journal of Immunology ·N. Yamaguchi, (unknown), Takao Mukai, (unknown), Xuyu Zhou, Shiro Ono, Mikihiko Kogo, Kyriaki Dunussi‐Joannopoulos, Vincent Ling, Stanley F. Wolf, Hiromi Fujiwara	12
10	Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2 2004 ·International Immunopharmacology ·Jing Li, (unknown), Xiangyang Tan, Paul W. Wu, Grace Yan, Vikki Spaulding, Bijia Deng, (unknown), (unknown), Ricardo de Lima Zollner, (unknown), Jill F. Wright, (unknown), Wei Liu, Kenneth Jacobs, Neil M. Wolfman, Vincent Ling, Debra D. Pittman, Geertruida M. Veldman, Lynette A. Fouser	55
11	Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease 2003 ·Genes and Immunity ·Yoshio Ban, Terry F. Davies, David A. Greenberg, (unknown), Brad A. Marder, Barbara Murphy, E S Concepcion, Ronald Villanueva, Giuseppe Barbesino, Vincent Ling, Yaron Tomer	66
12	Comparable in vivo efficacy of CD28/B7, ICOS/GL50, and ICOS/GL50B costimulatory pathways in murine tumor models: IFNγ-dependent enhancement of CTL priming, effector functions, and tumor specific memory CTL 2003 ·Cellular Immunology ·(unknown), Vincent Ling, Paul W. Wu, Hak‐Ling Ma, John P. Leonard, Mary Collins, Kyriaki Dunussi‐Joannopoulos	16
13	Inhibition of CTLA-4 Function by the Regulatory Subunit of Serine/Threonine Phosphatase 2A 2002 ·The Journal of Immunology ·Miren L. Baroja, Lalitha Vijayakrishnan, Estelle Bettelli, Peter J. Darlington, Thu Chau, Vincent Ling, Mary Collins, Beatriz M. Carreno, Joaquı́n Madrenas, Vijay K. Kuchroo	76
14	ICOS is critical for CD40-mediated antibody class switching breakdown → 2001 ·Nature ·Alexander J. McAdam, Rebecca J. Greenwald, (unknown), Tatyana Chernova, (unknown), Vincent Ling, (unknown), Arlene H. Sharpe	526
15	Cutting Edge: Identification of GL50, a Novel B7-Like Protein That Functionally Binds to ICOS Receptor 2000 ·The Journal of Immunology ·Vincent Ling, Paul W. Wu, Heather Finnerty, Kevin M. Bean, (unknown), Lynette A. Fouser, John P. Leonard, Sharon Hunter, Richard Zollner, (unknown), Joy Miyashiro, Kenneth Jacobs, Mary Collins	202
16	Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4+ T Cells 2000 ·The Journal of Immunology ·Alexander J. McAdam, Tammy T. Chang, (unknown), Edward Greenfield, Vassiliki A. Boussiotis, Jonathan S. Duke‐Cohan, Tatyana Chernova, (unknown), (unknown), Vijay K. Kuchroo, Vincent Ling, Mary Collins, Arlene H. Sharpe, Gordon J. Freeman	353
17	CTLA-4 (CD152) Can Inhibit T Cell Activation by Two Different Mechanisms Depending on Its Level of Cell Surface Expression 2000 ·The Journal of Immunology ·Beatriz M. Carreno, Frann Bennett, Thu Chau, Vincent Ling, Deborah Luxenberg, Jason Jussif, Miren L. Baroja, Joaquı́n Madrenas	216
18	Structural identification of the hematopoietic progenitor antigen ER‐MP12 as the vascular endothelial adhesion molecule PECAM‐1 (CD31) 1997 ·European Journal of Immunology ·Vincent Ling, Deborah Luxenberg, (unknown), Elliot Nickbarg, Pieter J. M. Leenen, S Neben, (unknown)	43
19	Ormaplatin resistance is associated with decreased accumulation of its platinum (II) analogue, dichloro(D,L-trans)1,2-diaminocyclohexaneplatinum (II) 1996 ·British Journal of Cancer ·Danny Rischin, Vincent Ling	5
20	Cellular Distribution of Calmodulin and Calmodulin-Binding Proteins in Vicia faba L. 1992 ·PLANT PHYSIOLOGY ·Vincent Ling, Sarah M. Assmann	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact